论文部分内容阅读
目的:肿瘤患者的血清前白蛋白(PA)明显降低存在组织损伤,引起慢性出血蛋白质丢失,使PA浓度降低,为临床诊断提供重要依据,但不少医院对检测血清PA还没有引起重视,应该及早将PA检测列入正常工作开展,这是发展趋势。方法:用罗氏/日立全自动生化分析仪采用体外免疫透射比浊法对肝、胃、肠道肿瘤患者进行血清PA含量检测。结果:测定胃癌(180.7±76.5)mg/L,肠道癌(204.85±80.3)mg/L,肝癌(157.8±68.2)mg/L均明显低于正常人(P<0.01)有显著意义。结论:检测PA可做为诊断恶性肿瘤的早期指标。
Objective: Tumor patients with pre-serum albumin (PA) significantly reduce the existence of tissue damage, causing chronic hemorrhagic protein loss, so that PA concentration, providing an important basis for clinical diagnosis, but many hospitals on the detection of serum PA has not attracted much attention, it should be PA testing included in the normal work as soon as possible, this is the development trend. Methods: Serum PA levels in patients with liver, stomach and intestine tumors were detected by Roche / Hitachi automatic biochemical analyzer using in vitro immunoturbidimetry. Results: The levels of gastric cancer (180.7 ± 76.5) mg / L, intestinal cancer (204.85 ± 80.3) mg / L, and liver cancer (157.8 ± 68.2) mg / L were significantly lower than those of normal controls (P <0.01). Conclusion: The detection of PA can be used as an early indicator of the diagnosis of malignant tumors.